Biomarker detects, regulates brain tumors

Nov 16, 2006

U.S. cancer researchers have identified a biomarker for brain tumors that also regulates the spread of intercranial tumors.

The Emory University scientists, in collaboration with researchers at the Dana Farber Cancer Institute, found the biomarker -- soluble attractin -- is elevated in the cerebrospinal fluid of patients with malignant astrocytoma, the most common form of brain tumors, and mediates glioma cell migration.

The biomarker is normally absent in the central nervous system and is undetectable in cerebral spinal fluid unless malignant astrocytomas are present in the CNS, the scientists said.

The discovery means physicians will have a new minimally invasive method to track the success of treatments, said Erwin Van Meir, professor of neurosurgery and lead author of the study.

He said the biomarkers, singly or in combination, will provide a fingerprint of the disease and be able, in the future, to better define the disease, suggest what kind of treatment to use and allow physicians to monitor how well the tumor responds to treatment.

The research is published in the November issue of the journal Clinical Cancer Research.

Copyright 2006 by United Press International

Explore further: Regulating the regulators: Degradation is key to the activity of the miR-21 oncomiR

add to favorites email to friend print save as pdf

Related Stories

Compressed diamond sheds light on mega-planets

23 minutes ago

Physicists in the United States on Wednesday reported they had compressed diamond to a density greater than that of lead, a technical feat that yields insights into the secrets of giant planets.

UP24 lifestyle bracelets take aim at waistlines

3 minutes ago

In the booming world of smart watches, pendants and bracelets that let people track sleep and steps, wearable computing pioneer Jawbone is out to win hearts through stomachs.

Recommended for you

User comments : 0